Lavina Lickley of the New Women's College Hospital, who led one portion of the study at four Toronto hospitals, said she was surprised that the two drugs "were almost dead-on equal." "I think it adds extra weight to the fact that in high-risk women,
http://c.moreover.com/click/here.pl?r510351920
http://c.moreover.com/click/here.pl?r510351920